Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
In an interview to CNBC-TV18's Latha Venkatesh, Anuj Singhal, and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks and sectors.
Axis Bank, SBI and M&M, among others, being tracked by analysts on Monday
Prakash Gaba of prakashgaba.com is of the view that Bata India can climb to Rs 830 while Aurobindo Pharma looks weak.
Watch the interview of SP Tulsian of sptulsian.com with Anuj Singhal, Latha Venkatesh and Surabhi Upadhyay on CNBC-TV18. He shared his readings and outlook on Rajratan Global Wire stock.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Mahindra & Mahindra Financial Services and buy Sun Pharmaceutical Industries, Tata Steel, Voltas and Page Industries.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Bajaj Finance and ICICI Prudential and can buy Tech Mahindra and Bharti Infratel while Britannia Industries is likely to outperform.
Mitessh Thakkar of miteshthacker.com has a sell on Cummins India below Rs 880, stop loss of Rs 896 for target of Rs 850 and a buy on Godrej Consumer with a stop loss of Rs 962 for target of Rs 1015.
Rajat Bose of rajatkbose.com recommends buying Aurobindo Pharma, Lupin and Balrampur Chini.
Ashwani Gujral of ashwanigujral.com suggests buying Steel Authority of India with a stop loss of Rs 84, target of Rs 96, a buy on BF Utilities with a stop loss of Rs 474, target of Rs 500 and a buy on Engineers India with a stop loss of Rs 188, target of Rs 202.
Aurobindo Pharma, L&T, Karnataka Bank, Indian Bank, REC Ltd, NTPC, DLF and Sun TV are looking attractive on technical setup.
Chandan Taparia of Motilal Oswal Securities recommends buying Aurobindo Pharma, Castrol India, Jain Irrigation Systems and Indraprastha Gas.
Adani Ports, Aurobindo Pharma, KPIT Technologies, Power Finance Corporation and Jain Irrigation could give up to 13% return in short term.
Ashwani Gujral of ashwanigujral.com suggests buying KNR Construction with a stop loss of Rs 270, target of Rs 287, a buy in Aurobindo Pharma with a stop loss of Rs 784, target of Rs 810 and a buy in JM Financial with a stop loss of Rs 168, target of Rs 182.
According to Technical Analyst Prakash Gaba of prakashgaba.com, the crucial support for the Nifty is at 10385-10240 and the resistance is at 10486-500. On the other hand, Bank Nifty has support at 25324 and resistance at 25650.
Sameet Chavan of Angel Broking is of the view that one may buy Adani Power with a target of Rs 36.80.
Ashwani Gujral of ashwanigujral.com recommends buying Natco Pharma, Aurobindo Pharma and Ajanta Pharma.
Rajat Bose of rajatkbose.com suggests buying Biocon, Ajanta Pharma and Aurobindo Pharma November futures while he feels that Infibeam Incorporation is likely to hit Rs 156.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Capital First and LIC Housing Finance and can buy Balkrishna Industries, Hindalco Industries and UltraTech Cement.
Mitessh Thakkar of miteshthacker.com advises buying Take Solutions, Just Dial, Aurobindo Pharma and Tata Power.
Gaurang Shah of Geojit Financial Services feels that Lupin may test Rs 1600.
Mitessh Thakkar of mitesshthakkar.com recommends a buy on Aurobindo Pharma above Rs 772 with stop loss of Rs 755 for target of Rs 810 and a buy on MRF with a stop loss of Rs 63,600 for target of Rs 67,000.
Prakash Gaba of prakashgaba.com likes Aurobindo Pharma for target of Rs 790 and JSW Energy for target of Rs 90.
Ashwani Gujral of ashwanigujral.com suggests buying Aban OffShore, Adani Ports and Aurobindo Pharma and feels that United Spirits is likely to test Rs 3,600.
Mitessh Thakkar of mitesshthakkar.com has recommends a buy on Mangalore Refinery and Petrochemicals which has a positive candlestick pattern with a stop loss of Rs 131 for target of Rs 140 while Ashwani Gujral of ashwanigujral.com has a buy on Maruti Suzuki with a stop loss of Rs 8000, target of Rs 8250.
CA Rudramurthy BV, Research Head at Vachana Investments recommends buying Aurobindo Pharma, Wockhardt and Suzlon Energy.